GlobalData on MSN1mon
Nevro secures CE mark for AI-based spinal cord stimulation system
Nevro is not the only player in the space using AI for pain management. A June 2024 real-world study of NXTSTIM’s ...
Fox 5 San Diego1mon
Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally
Nevro's comprehensive HFX™ spinal cord stimulation (SCS) platform includes the Senza ® SCS system and support services for the treatment of chronic pain of the trunk and limb and painful ...
Benzinga.com1mon
Why Medical Device Firm Nevro Stock Is Trading Higher On Tuesday
The company announced receiving CE Mark Certification in Europe for its HFX iQ spinal cord stimulation system. Nevro raised its 2024 adjusted EBITDA loss guidance to $18 million-$16 million ...
Benzinga.com1mon
A Look Ahead: Nevro's Earnings Forecast
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the ...
Yahoo Finance1mon
Nevro's HFX iQ™ Spinal Cord Stimulation with AI Technology Receives CE Mark Certification in Europe, Increasing Product Expansion Globally
today announced that it has received CE Mark Certification in Europe for its HFX iQ™ spinal cord stimulation (SCS) system. The CE marking allows Nevro to market HFX iQ in all countries that ...